NCT07214077

Brief Summary

The goal of this randomized controlled trial is to understand the feasibility and acceptability of a music-based mobile application to address chronic pain in people with HIV. Participants in the intervention group will use the Harmonized Healing music app daily, or as needed, for 3 months. Participants in the control group will receive psychoeducation on chronic pain and strategies for pain management. All participants will attend monthly follow-up visits during the 3-month intervention period, and an additional follow-up visit at Month 6.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
24mo left

Started Jun 2026

Typical duration for not_applicable chronic-pain

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

October 9, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

October 1, 2025

Last Update Submit

October 2, 2025

Conditions

Keywords

Chronic PainMusicsmartphone app

Outcome Measures

Primary Outcomes (10)

  • Intervention Feasibility: Recruitment

    Intervention feasibility will be assessed by the proportion of eligible individuals from the available recruitment pool.

    Month 3 Study Visits

  • Intervention Feasibility: Enrollment

    Intervention feasibility will be assessed by the proportion of eligible individuals who consent and enroll, and the proportion of the target sample size achieved.

    Month 3 Study Visits

  • Intervention Feasibility: Attrition

    Intervention feasibility will be assessed by the proportion of participants retained at each follow-up visit.

    Month 3 and Month 6 Study Visits

  • Intervention Feasibility: Adherence to Assessment Battery

    Intervention feasibility will be assessed by the proportion of participants who completed the assessment battery at each study visit. In the intervention condition, this includes the proportion of EMA completion.

    Month 3 and Month 6 Study Visits

  • Intervention Feasibility: FIM

    The Feasibility of Intervention Measure (FIM) is a 4-item Likert feasibility scale ranging from 1 (Completely disagree) to 5 (Completely agree). A mean score is calculated, resulting in a continuous score with higher scores indicating greater intervention feasibility.

    Month 3 Study Visit

  • Intervention Acceptability: Fidelity

    Intervention fidelity will be assessed by adherence to assigned study activities. In the intervention arm, this includes the proportion of days adherent to the prescribed app use. In the control arm, this includes the proportion of psychoeducation reviews completed before monthly visits.

    Month 3 Study Visit

  • Intervention Acceptability: Engagement (Percentage of days used)

    Intervention engagement will be assessed by the proportion of days with app use.

    Month 3 Study Visit

  • Intervention Acceptability: Engagement (Minutes engaged per week)

    Intervention engagement will be assessed by minutes of app engagement per week.

    Month 3 Study Visit

  • Intervention Acceptability: AIM

    The Acceptability of Intervention Measure (AIM) is a 4-item Likert agreeability scale ranging from 1 (Completely disagree) to 5 (Completely agree). A mean score is calculated, resulting in a continuous score with higher scores indicating greater intervention acceptability.

    Month 3 Study Visit

  • Intervention Acceptability: Qualitative Exit Interviews

    Intervention acceptability will be assessed via qualitative interviews exploring participants' lived experiences using the Harmonized Healing app, including facilitators and barriers to use, and engagement with the app.

    Month 3 Study Visit

Study Arms (2)

Harmonized Healing App

EXPERIMENTAL

Participants will receive psychoeducation related to drivers of chronic pain in the context of HIV and tips for managing pain, and the Harmonized Healing app. Participants will use the app at least once daily, or as needed, to manage and alleviate pain exacerbations for 3 months.

Behavioral: Harmonized Healing AppBehavioral: Psychoeducation

Control

ACTIVE COMPARATOR

Participants will receive psychoeducation related to drivers of chronic pain in the context of HIV and tips for managing pain. Participants will review the information at least once before each monthly visit (Month 1 to 3 Visits).

Behavioral: Psychoeducation

Interventions

A smartphone-driven music-based intervention designed to support daily or as-needed use of personalized music to manage and alleviate pain exacerbations.

Harmonized Healing App
PsychoeducationBEHAVIORAL

Educational materials on drivers of chronic pain in the context of HIV and strategies for pain management.

ControlHarmonized Healing App

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult ≥ 18 years old
  • Owns a smartphone
  • Living with HIV
  • Currently prescribed antiretroviral therapy (ART) for HIV
  • Experience with chronic pain (determined by self-reported pain of ≥3 on the Brief Pain Inventory for at least 3 months)

You may not qualify if:

  • Have a significant hearing loss
  • HIV-negative
  • Have been prescribed naltrexone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Chronic PainAcquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Peter Chai, MD, MMS

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Chai, MD, MMS

CONTACT

Peevara Srimanus, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 1, 2025

First Posted

October 9, 2025

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

June 1, 2028

Last Updated

October 9, 2025

Record last verified: 2025-10